Wael Barsoum, MD

216.444.2606

Wael Barsoum, MD

Appointed: 2003

Wael Barsoum, MD
Department: Orthopaedic Surgery
Vice Chair, Department of Orthopaedic Surgery
Location: Cleveland Clinic Main Campus
Mail Code A41
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.2606
DeskDesk:216.444.7515
WorkFax:216.445.6255
Wael Barsoum, MD
Department: Biomedical Engineering
Location: Cleveland Clinic Main Campus
Mail Code A41
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.2606
DeskDesk:216.444.7515
WorkFax:216.445.6255
Wael Barsoum, MD
Department: Medical Operations
Chair, Surgical Operations
Location: Cleveland Clinic Main Campus
Mail Code A41
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.2606
DeskDesk:216.444.7515
WorkFax:216.445.6255
Wael Barsoum, MD
Department: Executive Administration Florida
Interim CEO, Cleveland Clinic Florida
Location: Florida, Weston
Mail Code A41
2950 Cleveland Clinic Boulevard
Weston, FL 33331
WorkAppointment:216.444.2606
DeskDesk:216.444.2600
WorkFax:216.445.6255
Wael Barsoum, MD
Department: Executive Administration Florida
Interim CEO, Cleveland Clinic Florida
Location: Florida, Weston
Mail Code A41
2950 Cleveland Clinic Boulevard
Weston, FL 33331
WorkAppointment:216.444.2606
DeskDesk:216.444.2600
WorkFax:216.445.6255
Surgeon:
Yes
Treats:
Adults Only

Biographical Sketch

Wael Barsoum, MD, is Vice Chairman of the Department of Orthopaedic Surgery at Cleveland Clinic. He has become involved in the clinical leadership of the department and is an avid researcher and innovator.

His specialty interests include reconstructive surgery of the hip and knee joints, including arthroscopy, minimally invasive surgery of the hip and knee, and primary and revision joint replacements. He leads a productive research team, and he has written several articles and book chapters and has made numerous national and international presentations.

Dr. Barsoum completed his medical school training at The Ohio State University in 1995, and went on to finish his orthopaedic surgery residency training at Cleveland Clinic in 2000.  Dr. Barsoum served as Orthopaedic Surgery Chief Resident at Cleveland Clinic from 1999-2000. Following his residency, he completed advanced studies in Adult Reconstructive Surgery as an Otto E. Aufranc Fellow at the New England Baptist Hospital in Boston, Mass. Dr. Barsoum began his practice at Cleveland Clinic in Naples, Fla., and subsequently moved to the main hospital in Cleveland, Ohio, in 2003.

Professional Highlights

  • Dennis W. Jahnigen Career Development Scholar, 2007
  • CCF Innovations Award 2004, 2006, 2007

Education & Fellowships

Fellowship - New England Baptist Hospital
Adult Reconstructive Surgery
Boston, MA USA
2001
Residency - Cleveland Clinic
Orthopaedic Surgery
Cleveland, OH USA
2000
Medical School - The Ohio State University College of Medicine and Public Health
Columbus, OH USA
1995
Undergraduate - Case Western Reserve University
Cleveland, OH USA
1991

Certifications

  • Orthopaedic Surgery

Specialty Interests

Hip and knee reconstruction and replacement, hip and knee arthroscopy, revision knee replacement, revision hip replacement

Awards & Honors

  • Dennis W. Jahnigen Career Development Scholar, 2007
  • American Geriatrics Society, $150,000 over 2 years to examine the Role of Increasing Age and BMI in Outcomes Following Total Joint Replacement
  • Reviewer for Clinical Orthopaedics and Related Research, and Journal of Arthroplasty
  • Grant support from the American Geriatrics Association (Jahnigen Career Development Scholar), $150,000 over 2 years, Age and Body Mass Index as Preoperative Predictors of Outcomes in the Geriatric Population after Total Joint Arthroplasty, 2007
  • Grant Support from Zimmer (Principal Investigator), $215,410 over four years, Evaluation of the Trabecular Metal™ Acetabular Revision Cup using Dual-Energy X-ray Absorptiometry (DEXA) (pending)
  • Grant support from Orthopaedic Operating Room of the Future Program (Co-Investigator), $118,690, Department-wide Electronic Monitoring System (DEMOS) for On-site Collection of Surgical Outcomes
  • Grant support from Smith & Nephew (Co-Principal Investigator), $92,303, Kinematics of the Deuce Journey Partial Knee Implant (pending)
  • Grant support from Stryker Orthopaedics (Principal Investigator), $188,,000 over two years to study multiple projects including the use of Total Stabilized total knee arthroplasty components in two stage revision of TKA in infection, 2006
  • Grant support from Tissuelink, Principal Investigator, $201,000, A Prospective evaluation of the efficacy of radiofrequency cautery during total hip arthroplasty
  • Grant support from Tissuelink, $26,000, A Retrospective Review of Blood Loss Reduction Utilizing a Novel Cautery Device in Total Hip Arthroplasty
  • Grant support from Stryker Orthopaedics, $54,000, A Robotic Model of Instability in Total Knee Replacement
  • Stryker Orthopaedics, $9,000, ?Motion of the Proximal Fibula under Normal Loading Conditions, 2005
  • Grant support from Wright Medical Corporation, $10,000, Unrestricted Research Grant
  • Grant support from Exactech, $40,000 in engineering, software and statistical support for The Creation of a 3-Dimensional Computer Model of Impingement in Total Hip Replacement

Innovations & Patents

  • CCF Innovations Award, 2004, 2006, 2007
  • Designer, Exactech Novation Hip Replacement System
  • Designer, Wright Medical AVN Percutaneous Core Decompression Kit
  • Designer, Stryker Triathlon Total Stabilized Revision Knee System
  • Designer, Stryker SRK Unicompartmental Knee Replacement System
  • Designer, Stryker MIS Surgical Instruments for Total Knee Arthroplasty
  • Multiple patents have either been approved or are pending regarding bone fastener technology and instruments that aid in the removal of well-fixed implants. It is expected that these technologies will assist in revision joint replacement surgery to reduce the complexity of removal of well-fixed implants and to aid in improving fixation in bone.

Memberships

  • American Orthopaedic Association, 2007
  • Association of Bone and Joint Surgeons, 2007
  • American Academy of Orthopaedic Surgeons, 2006-Present
  • American Board of Orthopaedic Surgeons, 2003-Present
  • Cleveland Orthopaedic Society, 2003-Present

Treatment & Services

  • Arthritis Surgery
  • Arthroplasty
  • Complex Primary Hip Arthroplasty
  • Complex Primary Knee Arthroplasty
  • Fracture Non-union
  • Fracture Reconstruction
  • Hip & Knee Surgery
  • Hip Arthroscopy
  • Hip Osteotomy
  • Hip Replacement
  • Hip Revision
  • Joint Aspiration
  • Joint Reconstruction
  • Joint Replacement
  • Joint Replacement Of The Knee
  • Knee Arthroscopy
  • Knee Osteotomy
  • Knee Revision
  • Knee Surgery
  • Minimally Invasive Surgery
  • Orthopaedic Surgery
  • Primary And Revision Joint Replacements
  • Primary And Revision Total Hip Arthroplasty
  • Primary And Revision Total Knee Arthroplasty
  • Reconstructive Surgery Of The Hip
  • Reconstructive Surgery Of The Knee
  • Revision Hip Arthroplasty
  • Revision Hip Joint Replacement
  • Revision Joint Replacement
  • Revision Knee Arthroplasty
  • Revision Knee Joint Replacement
  • Revision Total Hip Replacement
  • Revision Total Knee Replacement
  • Surgical Treatment Of Arthritis Of The Hips And Knees
  • Therapeutic Injections
  • Total Hip And Total Knee Replacement
  • Total Joint Replacement
  • Total Knee Replacement
  • Viscosupplementation

Specialty in Diseases and Conditions

  • Arthritis
  • Arthritis Of The Hip
  • Arthritis Of The Knee
  • Avascular Necrosis Of The Hip
  • Avascular Necrosis Of The Knee
  • Hip Disorders
  • Hip Labral Tears
  • Joint Disorders
  • Knee Cartilage Injury
  • Knee Injuries
  • Knee Joint Disorders
  • Knee Ligament Injuries
  • Knee Pain
  • Rheumatoid Arthritis: How to Treat

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 6/19/2014, Dr. Barsoum has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Barsoum received fees of $5,000 or more per year as a paid consultant, speaker or member of an advisory committee for the following companies:

  • Stryker Corporation

Royalty Payments. Dr. Barsoum receives or has the right to receive royalty payments for inventions or discoveries commercialized through the companies shown below:

  • Custom Orthopaedic Solutions
  • Exactech, Inc.
  • Stryker Corporation
  • Zimmer, Inc.

Equity. Dr. Barsoum owns stock or stock options in the following companies for activities as a founder, inventor, discover, developer:

  • Custom Orthopaedic Solutions
  • iVHR

Right to Future Distribution of Cleveland Clinic Financial Interest. Dr. Barsoum may receive future financial benefits from the Cleveland Clinic for inventions or discoveries commercialized through the companies shown below:

  • Custom Orthopaedic Solutions
  • Exactech, Inc.
  • iVHR
  • Zimmer, Inc.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English
Cleveland Clinic Mobile Site